TY  - GEN
AU  - Wong,Michael K
AU  - Yang,Hongbo
AU  - Signorovitch,James E
AU  - Wang,Xufang
AU  - Liu,Zhimei
AU  - Liu,Nathan S
AU  - Qi,Cynthia Z
AU  - George,Daniel J
TI  - Comparative outcomes of everolimus, temsirolimus and sorafenib as second targeted therapies for metastatic renal cell carcinoma: a US medical record review
SN  - 1473-4877
PY  - 2014///1217
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Everolimus
KW  - Female
KW  - Humans
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Proportional Hazards Models
KW  - Protein Kinase Inhibitors
KW  - Retrospective Studies
KW  - Sirolimus
KW  - Sorafenib
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1185/03007995.2013.871243
ER  -